Search filters

List of works by Lisa Pleyer

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

scientific article published on 25 November 2014

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

scientific article

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

scientific article published on 16 April 2016

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

scientific article

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

scientific article published on 18 January 2014

Azacitidine in adult patients with acute myeloid leukemia

scientific article published on 03 June 2017

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group ⬇️

scientific article published on April 29, 2013

Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro.

scientific article

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

scientific article published on 14 April 2017

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group

scientific article published on 22 February 2018

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia ⬇️

scientific article published on January 5, 2013

Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab

scientific article published on 05 July 2011

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome

scientific article published on 15 October 2013

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

scientific article published on 01 September 2018

Digging deep into "dirty" drugs - modulation of the methylation machinery

scientific article published on 8 January 2015

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia

scientific article published in January 2018

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM

scientific article published on 28 February 2019

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

scientific article published on 30 January 2018

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

article published in 2018

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

scientific article published on 04 June 2018

Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

scientific article published on 01 January 2007

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

scientific article

Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

scientific article published on 02 June 2009

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

article by Michael Leisch et al published 21 February 2019 in Cancers

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.

scientific article published on 07 September 2011

Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights

scientific article published on October 2009

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

scientific article published on 02 May 2019

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation

scientific article published on 19 January 2017

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

scientific article published on 24 August 2017

Remission maintenance treatment options in chronic lymphocytic leukemia

scientific article published on 10 August 2018

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial

scientific article published on 19 March 2019

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

scientific article published on 16 June 2016

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

scientific article

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - An analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie

scientific article published on 01 June 2017

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

scientific article published on 3 January 2018

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial

scientific article published on 10 November 2018

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

scientific article published on 21 September 2017

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation

scientific article published on 31 March 2017

The impact of storage effects in biobanks on biomarker discovery in systems biology studies

scientific article published on 05 October 2010

Time to repeal and replace response criteria for acute myeloid leukemia?

scientific article published on 27 March 2018

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

scientific article published on 25 June 2014

Tumour-immune cell interactions modulated by chemokines

scientific article published in March 2008

Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.

scientific article published in November 2009

Paulina is supported by:

About Paulina

Help